Hamamatsu-shi, Shizuoka | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)	Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease	Active, not recruiting	Phase 3	2026-09-04		NCT04822181
Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not Closed	Growth Hormone Deficiency in Children	Enrolling by invitation	Not stated	2026-04-29		NCT06109935
Special Use - Results Surveillance on Long-term Use With Wegovy®	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition	Active, not recruiting	Not stated	2026-04-22		NCT06283667
Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®	Bone Diseases, Developmental, Bone Diseases, Endocrine, Dwarfism, bone disorder, brain disorder, central nervous system disorder, endocrine system disorder, hypopituitarism, hypothalamic disorder, musculoskeletal system disorder, nervous system disorder, pituitary dwarfism, pituitary gland disorder	Active, not recruiting	Not stated	2026-04-13		NCT05230550
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy	cardiovascular disorder, heart disorder, heart failure	Recruiting	Phase 2	2026-03-11		NCT06979375